查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1136946

EPA及DHA市場，各類型(二十碳五烯酸，二十二碳六烯酸)，供給來源，各用途，各地區- 規模，佔有率，展望，機會分析，2022年～2030年

EPA and DHA Market, By Type (Eicosapentaenoic Acid, Docosahexaenoic Acid ), By Source, By Application, By Geography - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
出版日期: | 出版商: Coherent Market Insights | 英文 153 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

市場動態

對濃縮 omega-3 成分不斷增長的需求正在顯著推動 EPA 和 DHA 市場的增長。

本調查的主要特徵

  • 本報告提供以2021年為基準年的預測期間（2022-2030 年）之全球EPA及DHA市場的市場規模和復合年增長率（CAGR %）相關的詳細分析。
  • 並闡明不同部門市場的潛在收入機會，說明該市場具有魅力的投資主張矩陣。
  • 同時並提供市場推動因素和限制、機會、新產品發布或批准、市場趨勢、區域前景和主要參與者採用的競爭戰略等重要考察。
  • 並基於企業亮點，各類型投資組合、主要焦點、財務業績和市場策略等參數，介紹全球EPA及DHA市場的主要參與者之企業簡介。
  • 藉由該報告提供的洞察，將能幫助營銷人員和公司高管能夠就未來的產品發布、類型升級、市場擴張和營銷策略做出明智的決策。
  • 全球EPA及DHA市場報告配合該行業的各種利益相關者，包括投資者、供應商、產品製造商、分銷商、新進入者和金融分析師。
  • 利益相關者可以透過全球EPA及DHA市場用於分析的各種戰略矩陣來幫助他們更容易做下決策。

目錄

第1章 調查目的與前提條件

  • 調查目的
  • 前提條件
  • 簡稱的說明

第2章 市場展望

  • 報告內容
    • 市場定義和範圍
  • 摘要整理
    • 市場明細:各類型
    • 市場明細:各來源
    • 市場明細，各應用領域
    • 市場明細，各地區
  • 連貫機遇地圖(COM)

第3章 市場動態，法規，趨勢分析

  • 市場動態
    • 由於健康意識的提高，對膳食補充劑的需求增加
    • 市場價格高
    • 主要參與者越來越關注探索 EPA 的提取過程
  • 影響分析
  • 主要的焦點
  • 法規方案
  • 產品的上市與核准
  • PEST分析
  • PORTER的分析
  • 合併·收購情景

第4章 EPA和DHA的全球市場:冠狀病毒(COVID-19)疫情的影響

  • COVID-19流行病學的特徵
  • 供給面和需求面分析
  • 經濟影響

第5章 EPA和DHA的全球市場:各類型，2017年～2030年

  • 二十碳五烯酸(EPA)
  • 二十二碳六烯酸(DHA)

第6章 EPA和DHA的全球市場:不同供應商，2017年～2030年

  • 魚油
  • 藻類油
  • 磷蝦油
  • 其他的來源

第7章 EPA和DHA的全球市場:各用途，2017年～2030年

  • 嬰幼兒配方奶粉
  • 營養補充品
  • 強化食品及食品和飲料
  • 醫藥品
  • 其他的用途

第8章 EPA和DHA的全球市場:各地區，2017年～2030年

  • 北美
  • 歐洲
  • 亞太地區
  • 南美
  • 中東·非洲
  • 全球其他地區

第9章 競爭情形

  • Koninklijke DSM NV
  • KD Pharma Group
  • The Archer Daniels Midland Company
  • Corbion NV
  • Novasep Holding SAS
  • Neptune Wellness Solutions
  • BASF SE
  • Clover Corporation Ltd
  • Croda International PLC
  • Others

第10章 章節

  • 調查手法的介紹
  • 關於出版社
簡介目錄
Product Code: CMI5200

EPA and DHA are fat-soluble omega-3 fatty acids that can be found in abundance in seafood, including fatty fish. They are also found in some grazed animal products. Although they are not the only source of EPA and DHA, they are essential for brain development. Research has indicated that EPA and DHA supplementation reduces the release of inflammatory factors, including IL-1B and granulocyte colony-stimulating factor. These findings indicate that EPA and DHA supplementation may be useful in preventing cognitive decline in people with mild to moderate Alzheimer's disease.

Market Dynamics:

Growing demand for concentrated form of omega-3 ingredients is predominantly fueling growth of the EPA and DHA market. Moreover, increasing demand for dietary supplements due to growing health awareness is again anticipated to foster market growth. Additionally, growing focus of key players to explore for extraction process for EPA is projected to provide significant growth opportunities over the forecast period. Furthermore, growing demand for vegan products and additives is gaining traction in the market.

On the Contrary, high market price is expected to hinder the market growth of EPA and DHA.

Key features of the study:

  • This report provides in-depth analysis of the global EPA and DHA market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2022-2030), considering 2021 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global EPA and DHA market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Koninklijke DSM NV, KD Pharma Group, The Archer Daniels Midland Company, Corbion NV, Novasep Holding SAS, Neptune Wellness Solutions, BASF SE, Clover Corporation Ltd, Croda International PLC, Novotech Nutraceuticals, and Polaris
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global EPA and DHA market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global EPA and DHA market

Detailed Segmentation:

  • Global EPA and DHA Market, By Type:
    • Eicosapentaenoic Acid (EPA)
    • Docosahexaenoic Acid (DHA)
  • Global EPA and DHA Market, By Source:
    • Fish Oil
    • Algae Oil
    • Krill Oil
    • Other Sources
  • Global EPA and DHA Market, By Application:
    • Infant Formulae
    • Dietary Supplements
    • Fortified Food and Beverages
    • Pharmaceuticals
    • Other Applications
  • Company Profiles
    • Koninklijke DSM NV*
      • Company Highlights
      • Products Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • KD Pharma Group
    • The Archer Daniels Midland Company
    • Corbion NV
    • Novasep Holding SAS
    • Neptune Wellness Solutions
    • BASF SE
    • Clover Corporation Ltd
    • Croda International PLC
    • Novotech Nutraceuticals
    • Polaris

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Type
    • Market Snippet, By Source
    • Market Snippet, By Application
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Increasing demand for dietary supplements due to growing health awareness
    • High market price
    • Growing focus of key players to explore for extraction process for EPA
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product launch/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Global EPA AND DHA Market- Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Global EPA AND DHA Market, By Type, 2017-2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2022 and 2030 (%)
    • Y-o-Y Growth Analysis, 2017 - 2030
    • Segment Trends
  • Eicosapentaenoic Acid (EPA)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)
  • Docosahexaenoic Acid (DHA)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)

6. Global EPA AND DHA Market, By Source, 2017-2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2022 and 2030 (%)
    • Y-o-Y Growth Analysis, 2017 - 2030
    • Segment Trends
  • Fish Oil
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Million)
  • Algae Oil
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Million)
  • Krill Oil
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Million)
  • Other Sources
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Million)

7. Global EPA AND DHA Market, By Application, 2017-2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2022 and 2030 (%)
    • Y-o-Y Growth Analysis, 2017 - 2030
    • Segment Trends
  • Infant Formulae
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Million)
  • Dietary Supplements
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Million)
  • Fortified Food and Beverages
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Million)
  • Pharmaceuticals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Million)
  • Other Applications
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Million)

8. Global EPA AND DHA Market, By Region, 2017-2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, By Country, 2022 and 2030 (%)
    • Y-o-Y Growth Analysis, For Country 2017-2030
    • Country Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2030,(US$ Mn)
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2030,(US$ Mn)
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2030,(US$ Mn)
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2030,(US$ Mn)
  • Middle East & Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2030,(US$ Mn)
  • Rest of World
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2030,(US$ Mn)

9. Competitive Landscape

  • Koninklijke DSM NV
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • KD Pharma Group
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • The Archer Daniels Midland Company
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Corbion NV
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Novasep Holding SAS
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Neptune Wellness Solutions
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • BASF SE
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Clover Corporation Ltd
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Croda International PLC
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Others
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Analyst Views

10. Section

  • Research Methodology
  • About us